New York City - June 29, 2004 - Manhattan Scientifics, Inc. (MHTX:OTC:BB) said today that the company is now fully reporting and its stock has resumed trading on the OTC Bulletin Board.
CEO Marvin Maslow said, "We were delisted in May 2003 as a result of our weak cash position that made it difficult to meet our reporting requirements. Although we still find it difficult to raise funds, we have been able to bring our audit and other payables up to date and resume our previous status as a fully reporting company. We are continuing our efforts to commercialize our technology into meaningful results for our shareholders."
Manhattan Scientifics, Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.